ClearPoint Neuro, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ClearPoint Neuro, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • ClearPoint Neuro, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $3.33M, a 15.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.33M -$626K -15.8% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.45M +$1.69M +95.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.56M +$1.67M +88.1% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $3.69M +$1.82M +97.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.96M +$1.96M +98.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.76M -$354K -16.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.9M -$346K -15.4% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $1.87M -$499K -21.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.99M -$497K -20% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $2.12M -$497K -19% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $2.24M -$495K -18.1% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $2.37M +$2.07M +703% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $2.49M +$2.17M +675% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.61M +$2.27M +652% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $2.74M +$2.36M +632% Dec 31, 2020 10-K 2022-03-09
Q3 2020 $295K -$106K -26.5% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $321K -$107K -25% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $348K -$7.49K -2.11% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $374K Dec 31, 2019 10-K 2021-03-22
Q3 2019 $401K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $428K Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $355K Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.